Gupta Wealth Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Gupta Wealth Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$16K	Buy	+300	New	+$22.1K	﹤0.01%	740

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Gupta Wealth Management's ANAC Position: Q1 2016 in Review

Gupta Wealth Management opened a new position in ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016: 300 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #740 among its holdings.

199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

Gupta Wealth Management held 300 shares of ANACOR PHARMACEUTICALS INC COM worth $16K as of Q1 2016.
ANACOR PHARMACEUTICALS INC COM was a new Gupta Wealth Management position in Q1 2016.
ANACOR PHARMACEUTICALS INC COM made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #740 holding.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.